Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Design, synthesis and selection of DNA-encoded small-molecule libraries.

Clark MA, Acharya RA, Arico-Muendel CC, Belyanskaya SL, Benjamin DR, Carlson NR, Centrella PA, Chiu CH, Creaser SP, Cuozzo JW, Davie CP, Ding Y, Franklin GJ, Franzen KD, Gefter ML, Hale SP, Hansen NJ, Israel DI, Jiang J, Kavarana MJ, Kelley MS, Kollmann CS, Li F, Lind K, Mataruse S, Medeiros PF, Messer JA, Myers P, O'Keefe H, Oliff MC, Rise CE, Satz AL, Skinner SR, Svendsen JL, Tang L, van Vloten K, Wagner RW, Yao G, Zhao B, Morgan BA.

Nat Chem Biol. 2009 Sep;5(9):647-54. doi: 10.1038/nchembio.211. Epub 2009 Aug 2. Erratum in: Nat Chem Biol. 2009 Oct;5(10):772.

PMID:
19648931
2.

Efficacy of a therapeutic cocaine vaccine in rodent models.

Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, Gefter ML, Exley MA, Swain PA, Briner TJ.

Nat Med. 1996 Oct;2(10):1129-32.

PMID:
8837612
3.

Peptide therapy for treatment of allergic diseases.

Wallner BP, Gefter ML.

Clin Immunol Immunopathol. 1996 Aug;80(2):105-9. Review. No abstract available.

PMID:
8764553
4.

Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy.

Falb D, Briner TJ, Sunshine GH, Bourque CR, Luqman M, Gefter ML, Kamradt T.

Eur J Immunol. 1996 Jan;26(1):130-5. Erratum in: Eur J Immunol 1996 Apr;26(4):966.

PMID:
8566055
5.

Immunotherapy with T-cell-reactive peptides derived from allergens.

Wallner BP, Gefter ML.

Allergy. 1994 May;49(5):302-8. Review. No abstract available.

PMID:
7522417
6.

Modulation of restricted class II T cell responses by peptides derived from self class II molecule.

Li WF, Fan MD, Pan CB, Gefter ML, Lai MZ.

Eur J Immunol. 1992 Oct;22(10):2527-31.

PMID:
1396959
7.

Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides.

Wang Y, Smith JA, Kamradt T, Gefter ML, Perkins DL.

Cell Immunol. 1992 Sep;143(2):284-97.

PMID:
1380894
8.

Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes.

Wang Y, Smith JA, Gefter ML, Perkins DL.

J Immunol. 1992 May 15;148(10):3034-41.

PMID:
1578129
9.
10.

Comparison of class I- and II-restricted T cell recognition of the identical peptide.

Perkins DL, Berriz G, Wang YS, Smith JA, Gefter ML.

Eur J Immunol. 1991 Nov;21(11):2781-9.

PMID:
1718759
11.

Immunodominance: intramolecular competition between T cell epitopes.

Perkins DL, Berriz G, Kamradt T, Smith JA, Gefter ML.

J Immunol. 1991 Apr 1;146(7):2137-44.

PMID:
1706388
12.

Interactions between immunogenic peptides and MHC proteins.

Rothbard JB, Gefter ML.

Annu Rev Immunol. 1991;9:527-65. Review.

PMID:
1910688
13.

Genetic recombination in the alpha 2 domain of the E alpha chain yields an Ed molecule with altered T cell activation.

Chang MY, Kowal C, Marzullo LR, Briner TJ, Gefter ML, Diamond B.

Eur J Immunol. 1990 Dec;20(12):2571-6.

PMID:
2148522
15.
16.

Immunological activity of covalently linked T-cell epitopes.

Ria F, Chan BM, Scherer MT, Smith JA, Gefter ML.

Nature. 1990 Jan 25;343(6256):381-3.

PMID:
1689012
17.

Crystal structure of the antigen-binding fragment of the murine anti-arsonate monoclonal antibody 36-71 at 2.9-A resolution.

Rose DR, Strong RK, Margolies MN, Gefter ML, Petsko GA.

Proc Natl Acad Sci U S A. 1990 Jan;87(1):338-42.

18.

Identical peptides recognized by MHC class I- and II-restricted T cells.

Perkins DL, Lai MZ, Smith JA, Gefter ML.

J Exp Med. 1989 Jul 1;170(1):279-89.

19.

Murine MHC polymorphism and T cell specificities.

Roy S, Scherer MT, Briner TJ, Smith JA, Gefter ML.

Science. 1989 May 5;244(4904):572-5.

PMID:
2470147
20.

Preliminary crystallographic studies of the Fab fragment of an anti-azophenylarsonate antibody.

Lin SF, Coll M, Gefter ML, Margolies MN, Wang AH.

J Mol Biol. 1989 Apr 20;206(4):789-90.

PMID:
2738920
21.

Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.

Sharon J, Gefter ML, Wysocki LJ, Margolies MN.

J Immunol. 1989 Jan 15;142(2):596-601.

PMID:
2911012
22.

Gene conversion and the generation of antibody diversity.

Wysocki LJ, Gefter ML.

Annu Rev Biochem. 1989;58:509-31. Review. No abstract available.

PMID:
2673016
23.

Control of cellular and humoral immune responses by peptides containing T-cell epitopes.

Scherer MT, Chan BM, Ria F, Smith JA, Perkins DL, Gefter ML.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:497-504. No abstract available.

PMID:
2484168
24.

T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element.

Lai MZ, Huang SY, Briner TJ, Guillet JG, Smith JA, Gefter ML.

J Exp Med. 1988 Sep 1;168(3):1081-97.

25.

Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice.

Souroujon M, White-Scharf ME, Andreschwartz J, Gefter ML, Schwartz RS.

J Immunol. 1988 Jun 15;140(12):4173-9.

PMID:
2453571
26.

Identification of mutant monoclonal antibodies with increased antigen binding.

Pollock RR, French DL, Gefter ML, Scharff MD.

Proc Natl Acad Sci U S A. 1988 Apr;85(7):2298-302.

27.

T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes.

Lai MZ, Ross DT, Guillet JG, Briner TJ, Gefter ML, Smith JA.

J Immunol. 1987 Dec 15;139(12):3973-80.

PMID:
2961803
29.
30.

Evolution of antibody variable region structure during the immune response.

Manser T, Wysocki LJ, Margolies MN, Gefter ML.

Immunol Rev. 1987 Apr;96:141-62. Review.

PMID:
3298006
31.

Immunological self, nonself discrimination.

Guillet JG, Lai MZ, Briner TJ, Buus S, Sette A, Grey HM, Smith JA, Gefter ML.

Science. 1987 Feb 20;235(4791):865-70.

PMID:
2433769
32.

Molecular limitations on variable-gene junctional diversity.

Wysocki LJ, Manser T, Gridley T, Gefter ML.

J Immunol. 1986 Dec 15;137(12):3699-701. No abstract available.

PMID:
3097129
33.

Interaction of peptide antigens and class II major histocompatibility complex antigens.

Guillet JG, Lai MZ, Briner TJ, Smith JA, Gefter ML.

Nature. 1986 Nov 20-26;324(6094):260-2.

PMID:
2946957
35.
36.

Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody.

Sharon J, Gefter ML, Manser T, Ptashne M.

Proc Natl Acad Sci U S A. 1986 Apr;83(8):2628-31.

37.

Somatic evolution of variable region structures during an immune response.

Wysocki L, Manser T, Gefter ML.

Proc Natl Acad Sci U S A. 1986 Mar;83(6):1847-51.

38.

Cytolytic activity of antigen-specific T cells with helper phenotype.

Nakamura M, Ross DT, Briner TJ, Gefter ML.

J Immunol. 1986 Jan;136(1):44-7.

PMID:
2415627
39.

Combinational diversity within variable regions bearing the predominant anti-p-azophenylarsonate idiotype of strain A mice.

Wysocki LJ, Margolies MN, Huang B, Nemazee DA, Wechsler DS, Sato VL, Smith JA, Gefter ML.

J Immunol. 1985 Apr;134(4):2740-7.

PMID:
2982953
40.

The molecular evolution of the immune response.

Manser T, Wysocki LJ, Gridley T, Near RI, Gefter ML.

Immunol Today. 1985 Mar;6(3):94-101. doi: 10.1016/0167-5699(85)90024-6.

PMID:
25291538
43.

Influence of clonal selection on the expression of immunoglobulin variable region genes.

Manser T, Huang SY, Gefter ML.

Science. 1984 Dec 14;226(4680):1283-8.

PMID:
6334361
45.

Once-daily propranolol for hypertension.

Lopez LM, Gefter ML, Hemmes RJ.

Drug Intell Clin Pharm. 1984 Oct;18(10):812-5.

PMID:
6489162
46.

Monoclonal antibodies to Rhizobium meliloti and surface mutants insensitive to them.

Johansen E, Finan TM, Gefter ML, Signer ER.

J Bacteriol. 1984 Oct;160(1):454-7.

47.

Expression of a VHC kappa chimaeric protein in mouse myeloma cells.

Sharon J, Gefter ML, Manser T, Morrison SL, Oi VT, Ptashne M.

Nature. 1984 May 24-30;309(5966):364-7.

PMID:
6328310
49.

Expression and rearrangement of homologous immunoglobulin VH genes in two mouse strains.

Near RI, Juszczak EC, Huang SY, Sicari SA, Margolies MN, Gefter ML.

Proc Natl Acad Sci U S A. 1984 Apr;81(7):2167-71.

50.

Analysis of the anti-azobenzenearsonate response at the molecular level.

Gefter ML, Margolies MN, Near RI, Wysocki LJ.

Ann Immunol (Paris). 1984 Jan-Feb;135C(1):17-30.

PMID:
6712160

Supplemental Content

Loading ...
Support Center